Marek Dudziński
Impact in
-
- Eosinophilic Disorders and Syndromes
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Genomics and Rare Diseases
Papers in
-
- Chronic Myeloid Leukemia Treatments 3
- Acute Myeloid Leukemia Research 1
- Genetics 3
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Marek Hus (1 shared paper)Sławomira Kyrcz‐Krzemień (1 shared paper)Grzegorz Helbig (2 shared papers)Michał Nowicki (1 shared paper)Stanisława Bazan‐Socha (1 shared paper)Joanna Góra‐Tybor (3 shared papers)Tomasz Sacha (3 shared papers)Grzegorz Basak (2 shared papers)
In The Last Decade
Marek Dudziński
9 papers receiving 53 citations
Peers
Comparison fields: 5 of 30
- Rheumatology 27
- Genetics 18
- Health Informatics 2
- General Dentistry 1
- Hematology 7
Countries citing papers authored by Marek Dudziński
This map shows the geographic impact of Marek Dudziński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Dudziński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Dudziński more than expected).
Fields of papers citing papers by Marek Dudziński
This network shows the impact of papers produced by Marek Dudziński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Dudziński. The network helps show where Marek Dudziński may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Dudziński, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 25 | |
| 2 | 2023 | 13 | |
| 3 | 2018 | 5 | |
| 4 | 2022 | 4 | |
| 5 | 2016 | 3 | |
| 6 | 2009 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2021 | 1 | |
| 9 | 2019 | 1 | |
| 10 | 2025 | 0 | |
| 11 | 2018 | 0 |
About Marek Dudziński
Marek Dudziński is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Physiology, having authored 11 papers that have together received 55 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Acute Myeloid Leukemia Research (1 paper), Dermatological and COVID-19 studies (1 paper), Telomeres, Telomerase, and Senescence (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). The work is most often cited by research in Rheumatology (27 citations), Genetics (18 citations), Health Informatics (2 citations), General Dentistry (1 citation) and Hematology (7 citations). Marek Dudziński has collaborated with scholars based in Poland, Germany and Italy. Frequent co-authors include Marek Hus, Sławomira Kyrcz‐Krzemień, Grzegorz Helbig, Michał Nowicki, Stanisława Bazan‐Socha, Joanna Góra‐Tybor, Tomasz Sacha, Grzegorz Basak, Michał J. Dąbrowski and Ewa Chmielowska. Their work appears in journals such as Blood, Frontiers in Oncology, Medical Oncology, Dermatology and Therapy and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.